Literature DB >> 28852869

Bismuth adjuvant and adverse effects of chemotherapy: issues with statistical analyses.

Peter Dalgaard1, Claus Thorn Ekstrøm2, Dorte Kronborg1.   

Abstract

Entities:  

Year:  2017        PMID： 28852869     DOI： 10.1007/s00520-017-3859-5

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  1 in total

1.  Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study.

Authors:  Per Boye Hansen; Milena Penkowa
Journal:  Support Care Cancer       Date:  2016-12-13       Impact factor: 3.603
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.